Biochemistry · Water & Electrolytes
Extracellular fluid (ECF) constitutes approximately one-third of total body water and serves as the internal environment for cells, facilitating nutrient delivery, waste removal, and electrolyte balance. It is primarily composed of interstitial fluid and plasma, with key electrolytes including sodium (Na⁺), chloride (Cl⁻), and bicarbonate (HCO₃⁻), which regulate osmotic pressure, acid-base balance, and cellular function. Disruptions in ECF composition or volume can lead to life-threatening conditions such as dehydration, edema, or electrolyte imbalances.
Water and electrolyte homeostasis is tightly regulated by hormonal, renal, and neural mechanisms to maintain cellular and systemic function. The kidneys play a central role in adjusting water reabsorption and electrolyte excretion, while hormones like antidiuretic hormone (ADH), aldosterone, and natriuretic peptides modulate these processes. Understanding the biochemical principles underlying these mechanisms is essential for diagnosing and managing fluid and electrolyte disorders.
The ECF is divided into two main compartments: plasma (20% of ECF) and interstitial fluid (80% of ECF). Plasma is the liquid component of blood, rich in proteins like albumin, which contribute to oncotic pressure. Interstitial fluid bathes cells and lacks significant protein content, relying on hydrostatic and osmotic gradients for exchange with plasma. Sodium is the dominant cation in ECF, while chloride and bicarbonate are the primary anions, maintaining electroneutrality and osmotic balance.
ADH, secreted by the posterior pituitary, regulates water reabsorption in the renal collecting ducts by increasing aquaporin-2 channel expression. Osmoreceptors in the hypothalamus detect changes in plasma osmolality, triggering ADH release in response to dehydration. ADH also responds to volume depletion via baroreceptors, though osmolality is the primary stimulus. Deficiencies in ADH production or action lead to diabetes insipidus, characterized by excessive water loss and hypernatremia.
The RAAS is a hormonal cascade that regulates sodium and water balance, blood pressure, and extracellular volume. Renin, released by juxtaglomerular cells in response to low renal perfusion or hyponatremia, cleaves angiotensinogen to angiotensin I, which is converted to angiotensin II by angiotensin-converting enzyme (ACE). Angiotensin II promotes vasoconstriction, aldosterone secretion, and sodium reabsorption in the proximal tubule, while aldosterone enhances sodium reabsorption and potassium excretion in the distal nephron.
Potassium (K⁺) is the primary intracellular cation, with only 2% of total body potassium residing in the ECF. ECF potassium levels are tightly regulated to maintain resting membrane potentials and prevent cardiac arrhythmias. Acid-base disturbances directly affect potassium distribution; acidosis shifts potassium out of cells, while alkalosis promotes cellular uptake. The kidneys excrete excess potassium via aldosterone-sensitive channels in the collecting duct, with dietary intake and cellular shifts influencing plasma levels.
Common disorders include dehydration (water deficit), overhydration (water excess), hyponatremia (low sodium), hypernatremia (high sodium), hypokalemia (low potassium), and hyperkalemia (high potassium). Hyponatremia may result from excessive water intake, SIADH, or heart failure, while hypernatremia often reflects water loss or inadequate intake. Hypokalemia can cause muscle weakness and arrhythmias, whereas hyperkalemia may lead to fatal cardiac conduction abnormalities. Diagnosis relies on serum electrolyte measurements and clinical assessment of volume status.
Extracellular fluid is critical for maintaining cellular function, with sodium, chloride, and bicarbonate as its primary electrolytes. Water balance is regulated by ADH, while sodium and volume homeostasis are controlled by the RAAS and aldosterone. Potassium and acid-base balance are interdependent, with disruptions leading to significant clinical consequences. Understanding these mechanisms is essential for managing fluid and electrolyte disorders.
Fluid and electrolyte imbalances are common in hospitalized patients, particularly those with renal disease, heart failure, or endocrine disorders. For example, hyperkalemia in chronic kidney disease requires prompt treatment with insulin, glucose, or potassium binders to prevent cardiac arrest. Similarly, hyponatremia in SIADH may necessitate fluid restriction or vasopressin receptor antagonists. Accurate diagnosis and management rely on integrating biochemical principles with clinical findings.